multiplemyelomahub.com
Open in
urlscan Pro
206.189.247.86
Public Scan
Submitted URL: http://www.multiplemyelomahub.com//medical/-information//venetoclax/-bortezomib/-and/-dexamethasone/-in/-mm/-updated/-results/-fro...
Effective URL: https://multiplemyelomahub.com//medical/-information//venetoclax/-bortezomib/-and/-dexamethasone/-in/-mm/-updated/-results/-fro...
Submission: On October 09 via api from US — Scanned from GB
Effective URL: https://multiplemyelomahub.com//medical/-information//venetoclax/-bortezomib/-and/-dexamethasone/-in/-mm/-updated/-results/-fro...
Submission: On October 09 via api from US — Scanned from GB
Form analysis
3 forms found in the DOM<form class="sc-eNQAEJ jnosnH">
<div width="100%" class="sc-bdVaJa fwHnPy"><input placeholder="Search something..." class="sc-hMqMXs ehuoOp" value="">
<div class="sc-bdVaJa ctaqHx"><button type="submit" color="primary.base" font-size="1.3rem" height="40px" width="55px" class="sc-EHOje hFiRAo"><span class="sc-bxivhb ckHtGy"><svg aria-hidden="true" focusable="false" data-prefix="far"
data-icon="search" class="svg-inline--fa fa-search fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></span></button></div>
</div><button color="white" font-size="1.8rem" height="40px" width="38px" class="sc-EHOje chmDYJ"><span class="sc-bxivhb ckHtGy"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="times" class="svg-inline--fa fa-times fa-w-10 "
role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512">
<path fill="currentColor"
d="M207.6 256l107.72-107.72c6.23-6.23 6.23-16.34 0-22.58l-25.03-25.03c-6.23-6.23-16.34-6.23-22.58 0L160 208.4 52.28 100.68c-6.23-6.23-16.34-6.23-22.58 0L4.68 125.7c-6.23 6.23-6.23 16.34 0 22.58L112.4 256 4.68 363.72c-6.23 6.23-6.23 16.34 0 22.58l25.03 25.03c6.23 6.23 16.34 6.23 22.58 0L160 303.6l107.72 107.72c6.23 6.23 16.34 6.23 22.58 0l25.03-25.03c6.23-6.23 6.23-16.34 0-22.58L207.6 256z">
</path>
</svg></span></button>
</form>
<form class="sc-eNQAEJ jnosnH">
<div width="100%" class="sc-bdVaJa fwHnPy"><input placeholder="Search something..." class="sc-hMqMXs ehuoOp" value="">
<div class="sc-bdVaJa ctaqHx"><button type="submit" color="primary.base" font-size="1.3rem" height="40px" width="55px" class="sc-EHOje hFiRAo"><span class="sc-bxivhb ckHtGy"><svg aria-hidden="true" focusable="false" data-prefix="far"
data-icon="search" class="svg-inline--fa fa-search fa-w-16 " role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg></span></button></div>
</div><button color="white" font-size="1.8rem" height="40px" width="38px" class="sc-EHOje chmDYJ"><span class="sc-bxivhb ckHtGy"><svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="times" class="svg-inline--fa fa-times fa-w-10 "
role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 320 512">
<path fill="currentColor"
d="M207.6 256l107.72-107.72c6.23-6.23 6.23-16.34 0-22.58l-25.03-25.03c-6.23-6.23-16.34-6.23-22.58 0L160 208.4 52.28 100.68c-6.23-6.23-16.34-6.23-22.58 0L4.68 125.7c-6.23 6.23-6.23 16.34 0 22.58L112.4 256 4.68 363.72c-6.23 6.23-6.23 16.34 0 22.58l25.03 25.03c6.23 6.23 16.34 6.23 22.58 0L160 303.6l107.72 107.72c6.23 6.23 16.34 6.23 22.58 0l25.03-25.03c6.23-6.23 6.23-16.34 0-22.58L207.6 256z">
</path>
</svg></span></button>
</form>
POST //translate.googleapis.com/translate_voting?client=te
<form id="goog-gt-votingForm" action="//translate.googleapis.com/translate_voting?client=te" method="post" target="votingFrame" class="VIpgJd-yAWNEb-hvhgNd-aXYTce"><input type="text" name="sl" id="goog-gt-votingInputSrcLang"><input type="text"
name="tl" id="goog-gt-votingInputTrgLang"><input type="text" name="query" id="goog-gt-votingInputSrcText"><input type="text" name="gtrans" id="goog-gt-votingInputTrgText"><input type="text" name="vote" id="goog-gt-votingInputVote"></form>
Text Content
You need to enable JavaScript to run this app. All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma. THE MULTIPLE MYELOMA HUB USES COOKIES ON THIS WEBSITE. THEY HELP US GIVE YOU THE BEST ONLINE EXPERIENCE. BY CONTINUING TO USE OUR WEBSITE WITHOUT CHANGING YOUR COOKIE SETTINGS, YOU AGREE TO OUR USE OF COOKIES IN ACCORDANCE WITH OUR UPDATED COOKIE POLICY Yes, I accept cookies Join our How to sequence BCMA-directed therapies in early relapsed/ refractory multiple myeloma At the ESH 7th Translational Research Conference: Multiple Myeloma with Martin Kaiser, Mohamad Mohty, and Rakesh Popat Saturday, October 5, 2024 | 09:10-10:10 CEST Register now This independent educational activity is funded by GSK. All content is developed independently by the faculty. The funders are allowed no influence on the content of this activity. TRANSLATE Powered by Translate The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help. Steering CommitteeAbout UsNewsletterContact VISIT: ALL Hub AML Hub GvHD Hub Lupus Hub Lymphoma Hub MPN Hub PsOPsA Hub LOG IN You're logged in! Click here any time to manage your account or log out. Brought to you by LOG IN You're logged in! Click here any time to manage your account or log out. VIEW ALL CONTENT Steering CommitteeAbout UsNewsletterContact TypesTherapeuticsCongressesTrialsExpert OpinionsEducational ResourcesDRUG UPDATES VIEW ALL MULTIPLE MYELOMA TYPES Plasma cell dyscrasias Risk PCL-like MM Transplant-ineligible MM Chromosomal aberrations MM-related mutations View all Types VIEW ALL CONTENT 404 Page not found Brought to you by Delivering streamlined independent medical education to enhance clinical practice In partnership with Thank you to the funders of the Multiple Myeloma Hub. All content is developed independently by SES in collaboration with an expert steering committee; funders are allowed no direct influence on the content of the hub. Silver Platinum Platinum Silver Digital educational resources delivered on the Multiple Myeloma Hub is supported by an educational grant from Janssen Biotech, Inc. Interested in becoming a supporter? Please contact us. Terms and ConditionsCookie PolicyPrivacy PolicyNewsletter Copyright ©Multiple Myeloma Hub. 2017-2024. All rights reserved. All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma. Original text Rate this translation Your feedback will be used to help improve Google Translate